# Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft

> **NCT00814983** · PHASE1,PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 15 (actual)

## Conditions studied

- ALL
- ANLL
- MDS
- NHL

## Interventions

- **PROCEDURE:** Naive T-cell Depleted Stem Cell Transplant
- **PROCEDURE:** Stem Cell Transplant No Manipulation
- **DEVICE:** Isolex device from Baxter

## Key facts

- **NCT ID:** NCT00814983
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** IND approval for naive T-cell depletion not obtained
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814983, "Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00814983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*